Comparison of antimicrobial resistance profiles among extended-spectrum-β-lactamase-producing and acquired AmpC β-lactamase-producing Escherichia coli isolates from Canadian intensive care units

被引：26

作者：

Baudry, Patricia J. ^{[1
,2
]}

Nichol, Kim ^{[1
]}

DeCorby, Melanie ^{[1
,2
]}

Mataseje, Laura ^{[2
,3
]}

Mulvey, Michael R. ^{[2
,3
]}

Hoban, Daryl J. ^{[1
,2
]}

Zhanel, George G. ^{[1
,2
]}

机构：

[1] Hlth Sci Ctr, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada

[2] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB R3A 1R9, Canada

[3] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 05期

关键词：

D O I：

10.1128/AAC.01176-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 [微生物学]; 100705 [微生物与生化药学];

摘要：

Resistance profiles were compared among 18 extended-spectrum-beta-lactamase-producing (ESBL) and 27 acquired AmpC beta-lactamase-producing Escherichia coli isolates collected from Canadian intensive care units from 2005 to 2006. ESBL-producing E. coli isolates were more likely to be gentamicin resistant (P < 0.03), fluoroquinolone resistant (P < 0.0001), and multidrug resistant (P < 0.0001) than AmpC-producing E. coli isolates.

引用

页码：1846 / 1849

页数：4

共 13 条

[1]

Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada [J].

Boyd, DA ;

Tyler, S ;

Christianson, S ;

McGeer, A ;

Muller, MP ;

Willey, BM ;

Bryce, E ;

Gardam, M ;

Nordmann, P ;

Mulvey, MR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3758-3764

[2]

*CLIN LAB STAND I, 2006, METH DISK SUSC BACT

[3]

DECORBY MM, 2006, 46 INT C ANT AG CHEM, pC2

[4]

Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli:: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004) [J].

Deshpande, Lalitagauri A. ;

Jones, Ronald N. ;

Fritsche, Thomas R. ;

Sader, Helio S. .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (06) :578-581

[5]

Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales [J].

Hopkins, K. L. ;

Batchelor, M. J. ;

Liebana, E. ;

Deheer-Graham, A. P. ;

Threlfalla, E. J. .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (03) :180-192

[6]

Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals [J].

Mulvey, MR ;

Bryce, E ;

Boyd, DA ;

Ofner-Agostini, M ;

Land, AM ;

Simor, AE ;

Paton, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :358-365

[7]

Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals [J].

Mulvey, MR ;

Bryce, E ;

Boyd, D ;

Ofner-Agostini, M ;

Christianson, S ;

Simor, AE ;

Paton, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1204-1214

[8]

Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR [J].

Pérez-Pérez, FJ ;

Hanson, ND .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2153-2162

[9]

Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region:: Emergence of CTX-M-15-producing isolates [J].

Pitout, Johann D. D. ;

Church, Deirdre L. ;

Gregson, Daniel B. ;

Chow, Barbara L. ;

McCracken, Melissa ;

Mulvey, Michael R. ;

Laupland, Kevin B. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1281-1286

[10]

Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary [J].

Pitout, Johann D. D. ;

Gregson, Daniel B. ;

Church, Deirdre L. ;

Laupland, Kevin B. .

EMERGING INFECTIOUS DISEASES, 2007, 13 (03) :443-448

← 1 2 →